Aptose Biosciences Stock Forecast - Naive Prediction

APTO Stock  USD 0.19  0.01  5.56%   
The Naive Prediction forecasted value of Aptose Biosciences on the next trading day is expected to be 0.27 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.13. Aptose Stock Forecast is based on your current time horizon. Although Aptose Biosciences' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Aptose Biosciences' systematic risk associated with finding meaningful patterns of Aptose Biosciences fundamentals over time.
  
At this time, Aptose Biosciences' Fixed Asset Turnover is very stable compared to the past year. As of the 14th of December 2024, Asset Turnover is likely to grow to 0.05, while Inventory Turnover is likely to drop (139.3 T). . As of the 14th of December 2024, Common Stock Shares Outstanding is likely to grow to about 7.1 M, though Net Loss is likely to grow to (35.8 M).

Aptose Biosciences Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Aptose Biosciences' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
1997-06-30
Previous Quarter
8.3 M
Current Value
M
Quarterly Volatility
21.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Aptose Biosciences is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Aptose Biosciences value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Aptose Biosciences Naive Prediction Price Forecast For the 15th of December 2024

Given 90 days horizon, the Naive Prediction forecasted value of Aptose Biosciences on the next trading day is expected to be 0.27 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0006, and the sum of the absolute errors of 1.13.
Please note that although there have been many attempts to predict Aptose Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Aptose Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Aptose Biosciences Stock Forecast Pattern

Backtest Aptose BiosciencesAptose Biosciences Price PredictionBuy or Sell Advice 

Aptose Biosciences Forecasted Value

In the context of forecasting Aptose Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Aptose Biosciences' downside and upside margins for the forecasting period are 0 and 5.76, respectively. We have considered Aptose Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.19
0.27
Expected Value
5.76
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Aptose Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Aptose Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.5043
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0182
MAPEMean absolute percentage error0.0716
SAESum of the absolute errors1.1291
This model is not at all useful as a medium-long range forecasting tool of Aptose Biosciences. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Aptose Biosciences. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Aptose Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aptose Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptose Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.155.64
Details
Intrinsic
Valuation
LowRealHigh
0.255.0710.56
Details
1 Analysts
Consensus
LowTargetHigh
17.9419.7121.88
Details

Other Forecasting Options for Aptose Biosciences

For every potential investor in Aptose, whether a beginner or expert, Aptose Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aptose Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aptose. Basic forecasting techniques help filter out the noise by identifying Aptose Biosciences' price trends.

View Aptose Biosciences Related Equities

 Risk & Return  Correlation

Aptose Biosciences Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Aptose Biosciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Aptose Biosciences' current price.

Aptose Biosciences Market Strength Events

Market strength indicators help investors to evaluate how Aptose Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aptose Biosciences shares will generate the highest return on investment. By undertsting and applying Aptose Biosciences stock market strength indicators, traders can identify Aptose Biosciences entry and exit signals to maximize returns.

Aptose Biosciences Risk Indicators

The analysis of Aptose Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aptose Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aptose stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Aptose Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aptose Stock

  0.88VALN Valneva SE ADRPairCorr
  0.89ERNA Eterna TherapeuticsPairCorr

Moving against Aptose Stock

  0.94DYAI Dyadic InternationalPairCorr
  0.83ESPR Esperion TherapeuticsPairCorr
  0.7BMY Bristol Myers SquibbPairCorr
  0.53GILD Gilead Sciences Sell-off TrendPairCorr
  0.51DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Historical Fundamental Analysis of Aptose Biosciences to cross-verify your projections.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Return On Assets
(1.36)
Return On Equity
(6.94)
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.